The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $41.03

Today's change+1.52 +3.85%
Updated December 18 1:17 PM EST. Delayed by at least 15 minutes.
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $41.03

Today's change+1.52 +3.85%
Updated December 18 1:17 PM EST. Delayed by at least 15 minutes.

NU Skin Enterprises Inc up sharply

NU Skin Enterprises Inc is up sharply today, rallying (U.S.)$1.52 or 3.85% to (U.S.)$41.03. Over the last five days, shares have lost 4.45% and are down 70.32% for the last year to date. This security has underperformed the S&P 500 by 82.76% during the last year.

Key company metrics

  • Open(U.S.) $39.83
  • Previous close(U.S.) $39.51
  • High(U.S.) $41.05
  • Low(U.S.) $39.74
  • Bid / Ask(U.S.) $40.99 / (U.S.) $41.04
  • YTD % change-70.32%
  • Volume769,692
  • Average volume (10-day)1,238,400
  • Average volume (1-month)1,023,664
  • Average volume (3-month)1,543,065
  • 52-week range(U.S.) $38.12 to (U.S.) $140.50
  • Beta1.62
  • Trailing P/E9.42×
  • P/E 1 year forward9.63×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.38
  • Dividend yield3.36%
  • Trailing EPS(U.S.) $4.36
Updated December 18 1:17 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.00%

Based on its net profit margin of 9.00%, NU Skin Enterprises Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.50%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue6396506711,016
Total other revenue--------
Total revenue6396506711,016
Gross profit530494564851
Total cost of revenue109156107165
Total operating expense534595570827
Selling / general / administrative425439463663
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income10555101189
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1063484192
Income after tax682055125
Income tax, total38142967
Net income682055125
Total adjustments to net income--------
Net income before extra. items682055125
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items682055125
Inc. avail. to common incl. extra. items682055125
Diluted net income682055125
Dilution adjustment--------
Diluted weighted average shares61616162
Diluted EPS excluding extraordinary itemsvalue per share1.120.320.902.02
Dividends per sharevalue per share0.350.350.350.30
Diluted normalized EPSvalue per share1.120.320.902.02